We are delighted to announce that Professor Thomas Jaki and Dr Oscar Rueda will be joining the MRC Biostatistics Unit in Programme Leader and Programme Leader Track positions.
Thomas has been Professor of Statistics at University of Lancaster, where he has led several substantial research projects and is head of Medical Statistics. His work has focused on developing and evaluating novel statistical methods for clinical and pre-clinical studies. These methods are adapted for specific applications to ensure they can be used in the pharmaceutical industry and also in public sector research institutions.
Thomas will be our new Programme Leader and Director of Research within the Design and Analysis of Randomised Trials (DART) theme, beginning in April for a transitional period while continuing to work with University of Lancaster, before taking on his role with the Unit full time. He will lead this continuously evolving research theme into a new era, developing new streams of clinical trials tackling current public health challenges, including COVID-19.
Oscar is coming to the Unit following a role as a Senior Research Associate in the Breast Cancer Functional Genomics Laboratory at the CRUK Cambridge Institute, where he has worked with all types of omics data, managing the analysis team that receives data from the Personalised Breast Cancer Program and produces reports that contain clinically actionable mutations.
Oscar will be joining the Unit in September, as a Programme Leader Track within the Statistical Omics (SOMX) theme. Oscar’s work will focus on developing cutting-edge statistical methods that can be used for clinical testing for breast cancer patients.
Welcome Thomas and Oscar!